Clinical trial
A Double-Blind Placebo Controlled Trial of Riluzole in Bipolar Depression
NCT00376220 · Johns Hopkins University, Other · Completed
Key facts
| NCT number | NCT00376220 |
|---|---|
| Title | A Double-Blind Placebo Controlled Trial of Riluzole in Bipolar Depression |
| Official title | A Double-Blind Placebo Controlled Trial of Riluzole in Bipolar Depression |
| Lead sponsor | Johns Hopkins University, Other |
| Collaborators | Stanley Medical Research Institute |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug, Other |
| Interventions | Riluzole, Placebo |
| Enrollment | 94 |
| Start date | May 1, 2004 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Sep 14, 2006 |
| Last update posted | Apr 11, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: